These results suggest that SOCS1 tumour-promoting effect in these CRC cells is unlikely to stem from an overall loss in the integrity of its SH2 or SOCS box domains, or invalidation of its E3 ubiquitin ligase activity. The gene discussed is SOCS1; the disease is neoplasm.